Updates

Second Opinion: The Truth About The Big Pharma Bailout

Sep 25, 2018

In their latest attempt to make billions of dollars on the backs of patients, Read More

Stop Big Pharma’s $4 Billion Bailout

Sep 21, 2018

As the country is hoping for lower drug prices, more affordable care Read More

CSRxP Statement on Potential Big Pharma Bailout

Sep 21, 2018

“Only Big Pharma would use bipartisan opioid legislation as another Read More

CSRxP Statement On Exclusion Of Big Pharma Accountability Amendment In Appropriations Bill

Sep 13, 2018

House Misses Bipartisan Opportunity To Hold Big Pharma Accountable Read More

SECOND OPINION: Big Pharma Continues Pointing Fingers for Excessive Drug Prices

Sep 12, 2018

Apparently, when it comes to out-of-control drug prices, everyone’s to blame Read More

Second Opinion: The Real Source of Rising Drug Prices

Sep 10, 2018

Big Pharma is always eager to play the blame game – attempting to divert Read More

CSRxP Urges House Members To Maintain Transparency Provision In Senate-Passed Appropriations Bill

Aug 29, 2018

CSRxP-Supported Policy Enables HHS To Require Drug Price Disclosure In Read More

CSRxP Applauds Senate Action To Boost Drug Price Transparency For Consumers

Aug 24, 2018

Legislation Includes CSRxP-Supported Amendment Enabling HHS To Require Read More

CSRxP Urges FDA To Finalize Guidance Critical To Lower Drug Prices

Aug 23, 2018

The Campaign for Sustainable Rx Pricing (CSRxP) today joined more than a dozen Read More

CSRxP Letter of Support for Durbin-Grassley DTC Advertising Amendment

Aug 21, 2018

Last night, Senators Durbin and Grassley filed an amendment to the Labor-HHS Read More

CSRxP Applauds Trump Administration’s Focus on Out-of-Control Drug Prices

Aug 21, 2018

CSRxP spokesman Will Holley released the following statement applauding the Read More

CSRxP Statement on CMS Changes to Medicare Part B

Aug 7, 2018

CSRxP spokesman Will Holley released the following statement following Read More